253 related articles for article (PubMed ID: 11958526)
1. Semicarbazide-sensitive amine oxidase (SSAO) in the brain.
Obata T
Neurochem Res; 2002 Apr; 27(4):263-8. PubMed ID: 11958526
[TBL] [Abstract][Full Text] [Related]
2. Effect of antidepressant drug on semicarbazide-sensitive amine oxidase (SSAO) in dog brain.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():3-12. PubMed ID: 25022027
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monkey brain semicarbazide-sensitive amine oxidase by various antidepressants.
Obata T; Yamanaka Y
Neurosci Lett; 2000 Jun; 286(2):131-3. PubMed ID: 10825654
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
5. Effect of antidepressant drug on semicarbazide-sensitive amine oxidase (SSAO) in dog brain.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):3-12. PubMed ID: 22032087
[TBL] [Abstract][Full Text] [Related]
6. Endogenous semicarbazide-sensitive amine oxidase (SSAO) inhibitor increases 1-methyl-4-phenylpyridinium ion (MPP+)-induced dopamine efflux by immobilization stress in rat striatum.
Obata T
Int J Dev Neurosci; 2006 Aug; 24(5):343-7. PubMed ID: 16725303
[TBL] [Abstract][Full Text] [Related]
7. Evidence for existence of thyroid hormone inducible semicarbazide-sensitive amine oxidase (SSAO) in rat heart cytosol.
Obata T; Nakashima M
Indian Heart J; 2016; 68(2):225-30. PubMed ID: 27133345
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
Fitzgerald DH; Tipton KF
J Neural Transm (Vienna); 2002 Mar; 109(3):251-65. PubMed ID: 11956949
[TBL] [Abstract][Full Text] [Related]
9. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
10. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C
Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359
[TBL] [Abstract][Full Text] [Related]
11. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
12. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
13. Absence of tissue-bound semicarbazide-sensitive amine oxidase activity in carp tissues.
Takahashi K; Kakuta I; Sugimoto H; Obata T; Oreland L; Kinemuchi H
Life Sci; 2007 Feb; 80(12):1094-9. PubMed ID: 17215008
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp.
Vavilova T; Ostrovskaya I; Axenova L; Buneeva O; Medvedev A
Med Sci Monit; 2009 Oct; 15(10):BR289-292. PubMed ID: 19789505
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase and semicarbazide-sensitive amine oxidase activities in bovine eye.
Fernandez de Arriba A; Balsa D; Tipton KF; Unzeta M
J Neural Transm Suppl; 1990; 32():327-30. PubMed ID: 2128504
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.
Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P
Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412
[TBL] [Abstract][Full Text] [Related]
18. Some aspects of the pharmacology of semicarbazide-sensitive amine oxidases.
Callingham BA; Holt A; Elliott J
J Neural Transm Suppl; 1990; 32():279-90. PubMed ID: 2128500
[TBL] [Abstract][Full Text] [Related]
19. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
20. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems.
Ochiai Y; Itoh K; Sakurai E; Adachi M; Tanaka Y
Biol Pharm Bull; 2006 Dec; 29(12):2362-6. PubMed ID: 17142964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
